Skip to main content

EDITORIAL article

Front. Immunol.
Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1503776
This article is part of the Research Topic Treat-to-target in systemic lupus erythematosus: Cytokine Transduction Pathways in SLE View all 7 articles

Editorial: Treat-to-target in systemic lupus erythematosus: Cytokine Transduction Pathways in SLE

Provisionally accepted
Yuji Nozaki Yuji Nozaki 1*Jennifer L. Barnas Jennifer L. Barnas 2
  • 1 Kindai University Hospital, Osakasayama, Japan
  • 2 University of Rochester Medical Center, Rochester, New York, United States

The final, formatted version of the article will be published soon.

    Keywords: cytokine network, SLE, treat to target, Novel therapeutic agent, cytokine signaling pathways

    Received: 29 Sep 2024; Accepted: 30 Sep 2024.

    Copyright: © 2024 Nozaki and Barnas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Yuji Nozaki, Kindai University Hospital, Osakasayama, Japan

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.